Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.clon.2021.08.003
PubMed Identifier: 34479769
Publication URI: http://europepmc.org/abstract/MED/34479769
Type: Journal Article/Review
Volume: 34
Parent Publication: Clinical oncology (Royal College of Radiologists (Great Britain))
Issue: 1
ISSN: 0936-6555